Classes of Drugs that Mitigate Radiation Syndromes
We previously reported several vignettes on types and classes of drugs able to mitigate acute and, in at least one case, late radiation syndromes in mice. Most of these had emerged from high throughput screening (HTS) of bioactive and chemical drug libraries using ionizing radiation-induced lymphocy...
Main Authors: | Ewa D. Micewicz, Robert D. Damoiseaux, Gang Deng, Adrian Gomez, Keisuke S. Iwamoto, Michael E. Jung, Christine Nguyen, Andrew J. Norris, Josephine A. Ratikan, Piotr Ruchala, James W. Sayre, Dörthe Schaue, Julian P. Whitelegge, William H. McBride |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.666776/full |
Similar Items
-
Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes
by: Tracy Gasperetti, et al.
Published: (2021-05-01) -
Corrigendum: Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes
by: Tracy Gasperetti, et al.
Published: (2021-08-01) -
Acute Radiation Syndrome and the Microbiome: Impact and Review
by: Brynn A. Hollingsworth, et al.
Published: (2021-05-01) -
Radiomitigative Effects of Approved Hematopoietic Drugs on Mice Exposed to Lethal Total-body Irradiation
by: T. Nishida, et al.
Published: (2020-04-01) -
The Exploration of an Effective Medical Countermeasure Enhancing Survival and Hematopoietic Recovery and Preventing Immune Insufficiency in Lethally-Irradiated Mice
by: Wu, Tong
Published: (2020)